SCHEMBL24007993

SCHEMBL24007993

O=c1c(N=C=S)cc(C2CC2)cn1C[C@@H]1CC[C@@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26024125 1.00 — —
SCHEMBL24816350 1.00 — —
SCHEMBL26024079 0.83 — —
SCHEMBL24008149 0.83 — —
SCHEMBL24007992 0.77 SLC18A3 (0.33) —
SCHEMBL25746137 0.77 SLC18A3 (0.33) —
SCHEMBL24007755 0.77 SLC18A3 (0.33) —
SCHEMBL24007908 0.77 BRD4 (0.36) —
SCHEMBL24815035 0.77 SLC18A3 (0.33) —
SCHEMBL24007996 0.77 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021226261-A1 6-HETEROARYLOXY BENZIMIDAZOLES AND AZABENZIMIDAZOLES AS JAK2 INHIBITORS AJAX THERAPEUTICS, INC. (US) 2021-11-11 — — WO disclosed
Send feedback